Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis MS Al Yami, HA Badreldin, AH Mohammed, AM Elmubark, MY Alzahrani, ... Journal of thrombosis and thrombolysis 46, 145-153, 2018 | 15 | 2018 |
Evidence of Clinical and Economic Benefits of Clinical Pharmacist interventions in Warfarin Anticoagulant Therapy EAEG Bashier Osmana, Ahmed Almubarka, Iman H. Abdoona, Elkhansa Abelhamida International Journal of Pharmacy 104, 374-380, 2013 | 2* | 2013 |
Correction to: Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis MS Al Yami, A McBride, C Katragadda, JR Martin, HA Badreldin, ... Journal of Thrombosis and Thrombolysis 47 (1), 166-166, 2019 | 1 | 2019 |
Hyponatremia management among patients admitted to tertiary hospital: A retrospective evaluation S Zurnuq, M Aljurfi, M Albekery, MS Shawaqfeh, A Elmubark, ... SAGE Open Medicine 10, 20503121221095333, 2022 | | 2022 |
Comparison of Efficacy of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review M Alkahtani, A Elmubark, M Al Yami Indian Journal of Public Health Research & Development 11 (7), 1344-1350, 2020 | | 2020 |
Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A … A Elmubark, M Alkahtani, M Al Yami Indian Journal of Public Health Research & Development 11 (7), 1063-1069, 2020 | | 2020 |
Comparison Study between Real Life and Published Data Outcome among Myelofibrosis Patients Who are Using Ruxolitinib at King Abdulaziz Medical City-Central Region RB Yousef Alolah, Ahmed Alanazi, Ahmed Elmubark, Mohamed Albekery, Mohammed ... International Journal of Medical Research & Health Sciences 9 (1), 14-19, 2020 | | 2020 |